These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2202231)

  • 1. Placebo-controlled, double-blind study of the effect of verapamil in intermittent claudication.
    Kimose HH; Bagger JP; Aagaard MT; Paulsen PK
    Angiology; 1990 Aug; 41(8):595-8. PubMed ID: 2202231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of verapamil in intermittent claudication A randomized, double-blind, placebo-controlled, cross-over study after individual dose-response assessment.
    Bagger JP; Helligsoe P; Randsbaek F; Kimose HH; Jensen BS
    Circulation; 1997 Jan; 95(2):411-4. PubMed ID: 9008458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketanserin in intermittent claudication. A double-blind placebo-controlled study.
    Clement DL; Duprez D; Van Wassenhove A; Brusselmans F
    Int Angiol; 1989; 8(2):92-6. PubMed ID: 2681451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled, crossover study to assess the immediate effect of sublingual glyceryl trinitrate on the ankle brachial pressure index, claudication, and maximum walking distance of patients with intermittent claudication.
    Walker SR; Tennant S; MacSweeney ST
    J Vasc Surg; 1998 Nov; 28(5):895-900. PubMed ID: 9808859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized placebo-controlled, double-blind trial of ketanserin in claudicants. Changes in claudication distance and ankle systolic pressure. PACK Claudication Substudy.
    Circulation; 1989 Dec; 80(6):1544-8. PubMed ID: 2688971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ethaverine hydrochloride on the walking tolerance of patients with intermittent claudication.
    Trainor FS; Phillips RE; Michie DD; Zellner SR; Hogan L; Chubb JM
    Angiology; 1986 May; 37(5):343-51. PubMed ID: 3521401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
    Mortensen UM; Nielsen-Kudsk JE; Sondergaard HM; Jakobsen P; Jensen BS; Schmitz O; Nielsen TT
    Diabet Med; 2006 Mar; 23(3):327-30. PubMed ID: 16492219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-term study of policosanol in the treatment of intermittent claudication.
    Castaño G; Más Ferreiro R; Fernández L; Gámez R; Illnait J; Fernández C
    Angiology; 2001 Feb; 52(2):115-25. PubMed ID: 11228084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized clinical trial of angiotensin-converting enzyme inhibitor, ramipril, in patients with intermittent claudication.
    Shahin Y; Cockcroft JR; Chetter IC
    Br J Surg; 2013 Aug; 100(9):1154-63. PubMed ID: 23842829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, placebo-controlled study of the effects of policosanol in patients with intermittent claudication.
    Castaño G; Más R; Roca J; Fernández L; Illnait J; Fernández JC; Selman E
    Angiology; 1999 Feb; 50(2):123-30. PubMed ID: 10063942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketanserin in intermittent claudication: effect on walking distance, blood pressure, and cardiovascular complications.
    Thulesius O; Lundvall J; Kroese A; Stranden E; Hallböök T; Brunes L; Gjöres JE; Akesson H; Einarsson E; Ohlin P
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):728-33. PubMed ID: 2442541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of naftidrofuryl in patients with intermittent claudication.
    Karnik R; Valentin A; Stöllberger C; Slany J
    Angiology; 1988 Mar; 39(3 Pt 1):234-40. PubMed ID: 3281516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Placebo-controlled double-blind study of the effectiveness of Ginkgo biloba special extract EGb 761 in trained patients with intermittent claudication].
    Blume J; Kieser M; Hölscher U
    Vasa; 1996; 25(3):265-74. PubMed ID: 8967154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta blockade and intermittent claudication: placebo controlled trial of atenolol and nifedipine and their combination.
    Solomon SA; Ramsay LE; Yeo WW; Parnell L; Morris-Jones W
    BMJ; 1991 Nov; 303(6810):1100-4. PubMed ID: 1747577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of verapamil in intermittent claudication.
    Switzer DS
    J Fam Pract; 1997 Apr; 44(4):337. PubMed ID: 9108822
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and microcirculatory effects of transcutaneous CO2 therapy in intermittent claudication. Randomized double-blind clinical trial with a parallel design.
    Fabry R; Monnet P; Schmidt J; Lusson JR; Carpentier PH; Baguet JC; Dubray C
    Vasa; 2009 Aug; 38(3):213-24. PubMed ID: 19736632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind placebo-controlled trial of buflomedil in intermittent claudication.
    Fonseca V; Mikhailidis DP; Barradas MA; Jeremy JY; Gracey L; Dandona P
    Int J Clin Pharmacol Res; 1988; 8(5):377-81. PubMed ID: 3229875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up.
    Delis KT; Nicolaides AN; Wolfe JH; Stansby G
    J Vasc Surg; 2000 Apr; 31(4):650-61. PubMed ID: 10753272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of sublingual glyceryl trinitrate on walking distance in patients with intermittent claudication. A randomised, doubled-blind, placebo-controlled, cross-over study.
    Heer R; Walker S; MacSweeney S
    Curr Med Res Opin; 2001; 17(2):113-5. PubMed ID: 11759179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placebo-controlled trial of ketanserin in the treatment of intermittent claudication.
    Cameron HA; Waller PC; Ramsay LE
    Angiology; 1987 Jul; 38(7):549-55. PubMed ID: 3304029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.